NY State Informed Consent Tests - Mayo Clinic Laboratories
NY State Informed Consent Tests New York State clients are required by New York State regulations to have completed informed-consent forms on file. When ordering the following tests, all NYS clients are required to indicate to...
Learn more about Mayo Clinic Laboratories’ testing to identify and monitor nicotine use as part of a patient’s nicotine-use cessation treatment plan, before anesthesia/surgery, or as part of insurance policy assessments.
New tests launched in March - Insights
In March 2022, Mayo Clinic Laboratories announced eighteen new tests along with numerous reference value changes, obsolete tests, and algorithm changes.
autoimmune-paraneoplastic-gastrointestinal-dysmotility-evaluation-algorithm.pdf
© Mayo Foundation for Medical Education and Research (MFMER). All rights reserved. 05/2024 Autoimmune/Paraneoplastic Gastrointestinal Dysmotility Evaluation Algorithm ■ PCA-2 IFA titer■ ANNA-1 antibody by immunoblot ■ ANNA-2 antibody...
autoimmune-paraneoplastic-dysautonomia-evaluation-algorithm.pdf
© Mayo Foundation for Medical Education and Research (MFMER). All rights reserved. Autoimmune/Paraneoplastic Dysautonomia Evaluation Algorithm 05/2024 ■ AP3B2 antibody by CBA ■ AP3B2 antibody by IF titer assay ■ PCA-2 IFA titer■ ANNA-1...
Autoimmune Movement Disorders - Mayo Clinic Laboratories
Our phenotype specific testing for autoimmune movement disorders contain clinically relevant antibodies providing accurate answers for treatment guidance.
There have been concerns in the U.S. recently about the possible harmful side effects from absorbing gadolinium-based contrast agents into the body during some MRI exams. To address some of the anxiety and concerns over this issue, Paul...
IgA-mediated autoimmune bullous dermatoses - Insights
In this month’s “Hot Topic,” Julia Lehman, M.D., will discuss autoimmune bullous dermatoses, the rare category of blistering skin diseases that are caused by the development of autoantibodies against various constitutive parts of the...
Nonradioactive assay helps diagnose heparin reaction - Insights
Rajiv Pruthi, M.B.B.S., explains how Mayo Clinic Laboratories’ serotonin release assay achieves high sensitivity and specificity while avoiding the use of radioactive materials. Serotonin release testing is an important tool in the...
https://news.mayocliniclabs.com/mc2775-782/
FO U R RE AL -W O RL D C O LL AB O RA TI VE E XA M PL ES to Mayo Clinic diagnostics C O N N E C T I N G Pharma and biotech TABLE OF CONTENTS What makes a good testing partner? Case study 1 Gastrointestinal study collects and tests...
Find out how our data-driven testing was developed by experts and uses innovative laboratory technology to monitor all stages of kidney disease.
New tests launched in October - Insights
In October 2020, Mayo Clinic Laboratories announced two new tests along with numerous reference value changes, obsolete tests, and algorithm changes.
New Tests Launched in March - Insights
In March 2019, Mayo Clinic Laboratories announced six new tests along with numerous reference value changes, obsolete tests, and algorithm changes.
Learn more about how related prenatal testing at Mayo Clinic Laboratories can help determine the best course for managing a pregnancy.
Test Classification Updates - Mayo Clinic Laboratories
Share Print Web: mayocliniclabs.com...
Demyelinating neuropathies - Insights
Learn how our expert-backed testing can increase confidence when it comes to the identification of several demyelinating neuropathies.
myeloproliferative_neoplasm_a_diagnostic_approach_to_peripheral_blood_evaluation.pdf
05/2023© Mayo Foundation for Medical Education and Research (MFMER). All rights reserved. *A minor criterion for PV **In the appropriate clinicopathologic setting Myeloproliferative Neoplasm: A Diagnostic Approach to Peripheral Blood...
MCL Blood Spot Collections Instructions Flyer MC4091135
MCL Blood Spot Collections Instructions Flyer Blood Spot Collection Instructions Instructions Blood Collection Heelstick Fingerstick minutes place warmer
CPT codes and LOINC update: December 2024 - Insights
This will be the last CPT Codes and LOINC update. Read why.
CPT codes and LOINC update: March 2022 - Insights
CPT Code updates posted to mayocliniclabs.com during the month of
New Tests Launched in May - Insights
In May 2017, Mayo Medical Laboratories announced eight brand new tests along with numerous reference value changes, obsolete tests, and algorithm changes.
New Tests Launched in March - Insights
In March 2018, Mayo Medical Laboratories announced fifteen new tests along with numerous reference value changes, obsolete tests, and algorithm changes.
See how our unique panel includes testing for antibodies proven to be associated with paraneoplastic or cancer-associated retinopathy.
New tests launched in August - Insights
In August 2021, Mayo Clinic Laboratories announced three new tests along with numerous reference value changes, obsolete tests, and algorithm changes.
New tests launched in February - Insights
In February 2021, Mayo Clinic Laboratories announced three new tests along with numerous reference value changes, obsolete tests, and algorithm changes.
New Tests Launched in July - Insights
In July 2018, Mayo Medical Laboratories announced five new tests along with numerous reference value changes, obsolete tests, and algorithm changes.
New Tests Launched in February - Insights
In February 2017, Mayo Medical Laboratories announced nine brand new tests along with numerous reference-value changes, obsolete tests, and algorithm changes.
parasitic_investigation_of_stool_specimens_algorithm.pdf
© Mayo Foundation for Medical Education and Research (MFMER). All rights reserved. 06/2023 Parasitic Investigation of Stool Specimens Algorithm Patients with watery diarrhea Risk factors for parasitic infection include: ■ AIDS ■ ≤5 years...
myeloproliferative_neoplasm_a_diagnostic_approach_to_bone_marrow_evaluation.pdf
© Mayo Foundation for Medical Education and Research (MFMER). All rights reserved. 08/2023 Myeloproliferative Neoplasm: A Diagnostic Approach to Bone Marrow Evaluation Clinical suspicion of myeloproliferative neoplasm Consistent with...
MCL - Renal Biopsy Patient Information - MC1235-45
MCL - Renal Biopsy Patient Information
IMPACTS Team Continues to Combat Life-Threatening Arthropod-Borne Infections in Belize - Insights
Now in its second year of a five-year initiative to better understand and detect arboviruses in Belize, the IMPACTS (Integrated Mayo Clinic Program for Arbovirus Community health education Training and Surveillance) project has expanded its...
New tests launched in November - Insights
In November 2021, Mayo Clinic Laboratories announced thirty four new tests along with numerous reference value changes, obsolete tests, and algorithm changes.
Autoimmune Axonal Evaluation [Test in Focus] - Insights
Divyanshu Dubey, M.B.B.S. gives an overview of this test available through Mayo Clinic Laboratories. He discusses when this testing should be ordered, how this testing compares to other testing approaches, and what clinical action can be...
New Tests Launched in October - Insights
In October 2017, Mayo Medical Laboratories announced eight new tests along with numerous reference value changes, obsolete tests, and algorithm changes.
erythrocytosis_evaluation_testing_algorithm.pdf
03/2023© Mayo Foundation for Medical Education and Research (MFMER). All rights reserved. Erythrocytosis Evaluation Testing Algorithm Testing begins with: PVJAK / Polycythemia Vera, JAK2 V617F with Reflex to JAK2 Exon 12-15, Sequencing...
New tests launched in September - Insights
In September 2022, Mayo Clinic Laboratories announced ten new tests along with numerous reference value changes, obsolete tests, and algorithm changes.
New tests launched in November - Insights
Mayo Clinic Laboratories launched the following three tests in November.
Necrotizing Autoimmune Myopathy Testing - Mayo Clinic Laboratories
We offer advanced testing of the most pertinent antibodies associated with IMNM on a sensitive immunofluorescence-based assay providing fast results for patients.
New tests launched in September - Insights
In September 2021, Mayo Clinic Laboratories announced seven new tests along with numerous reference value changes, obsolete tests, and algorithm changes.
Mayo Clinic Laboratories releases new, first-to-U.S.-market pregnancy risk assessment - Insights
Mayo Clinic Laboratories now offers the first preeclampsia-specific test (Mayo ID: PERA) that can be used to stratify patients into low or high-risk categories, indicating whether a patient is at risk for developing preeclampsia with severe...
inflammatory-bowel-disease-diagnostic-testing-algorithm.pdf
YES <50 mcg/g <50 mcg/g Abnormal >50 mcg/g Normal ANCA present ASCA IgG and IgA absent ANCA absent ASCA IgG or IgA present ANCA absent ASCA IgG or IgA absent >120 mcg/g50-120 mcg/g NO Assessing a patient with diarrhea when differential...
Aiming to advance understanding of hard-to-predict gastroenteropancreatic neuroendocrine tumors (GEP-NETs), Thermo Fisher Scientific joined forces with Mayo Clinic and BioPharma Diagnostics to validate and gain U.S. regulatory clearance of...
Autoimmune Encephalitis Misdiagnosis - Insights
In this month's "Hot Topic," Eoin Flanagan, M.B., B. Ch., discusses the important issue of autoimmune encephalitis misdiagnosis and identifies red flags that be useful in clinical practice to suggest alternative diagnoses and highlight...
MCL Erythrocytosis Patient Information MC1235177
MCL Erythrocytosis Patient Information Complete print Reset Form Erythrocytosis Patient Information Instructions accurate interpretation reporting results contingent
congenital-disorders-of-glycosylation-algorithm.pdf
Unexplained developmental delay, multisystemic disease with or without a neurologic component, multiple unexplained abnormalities of basic laboratory resultsa ■ CDGN - consistent with type I CDG (congenital disorder of glycosylation)...
Nuclear Magnetic Resonance Lipoprotein Profile [Test in Focus] - Insights
Jeffrey (Jeff) Meeusen, Ph.D., gives an overview of the new nuclear magnetic resonance (NMR) lipoprotein profile available through Mayo Clinic Laboratories. He discusses when this testing should be ordered, how this testing improves upon...
MCL - Chain of Custody Request - MC1944
MCL - Chain of Custody Request
Autoimmune evolution - Insights
Mayo Clinic Laboratories is leading an evolution in autoimmune neurology diagnosis. To better reflect this testing evolution, and to reduce confusion and improve utilization for our clients, effective April 28, we are renaming our...
New tests launched in April - Insights
In April 2022, Mayo Clinic Laboratories announced fourteen new tests along with numerous reference value changes, obsolete tests, and algorithm changes.